InterVene Receives FDA Clearance for Venous Thrombectomy System
Post-thrombotic syndrome affects an estimated 20 to 50% of patients after proximal deep vein thrombosis, with severe cases in 5 to 10% of patients. Venous in-stent restenosis—a narrowing of veins where stents have been placed—poses treatment challenges for patients with […]
InterVene Receives FDA Clearance for Venous Thrombectomy System Read More »










